Product Information

PITAVASTATIN 1 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.7973 per EA under NDC 65162002909. Its NADAC has been published 81 times since May 7, 2025.

FDA first approved this application on Aug 20, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PITAVASTATIN 1 MG TABLET

Pitavastatin
$0.7973per EA

Strength

1 mg/1

NDC

65162002909

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PITAVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA205961

FDA Approved

8/20/2024

TE Code

AB

On Market Since

8/21/2024

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PITAVASTATIN 1 MG TABLET has been published 81 times since May 7, 2025, and over the history we have for it it has declined 51.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7973 per EA
All-time high$1.6402 (May 14, 2025)
All-time low$0.7973 (Nov 18, 2026)
52-week high$1.5698
52-week low$0.7973
Median price$1.3410
Average price$1.3115
Largest weekly change-12.4% (Jan 21, 2026)
Weeks tracked81
Tracking sinceMay 7, 2025

Price History

1W

-4.7%

1M

-11.8%

3M

-20.1%

6M

-33.5%

1Y

-49.2%

3Y

N/A

5Y

N/A

All

-51.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PITAVASTATIN 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 1 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.7973 per EA (NDC 65162002909), effective Nov 18, 2026.

How has the price of PITAVASTATIN 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for PITAVASTATIN 1 MG TABLET has declined 51.4%. It has been tracked across 81 weekly CMS publications since May 7, 2025.

What are the highest and lowest recorded NADAC prices for PITAVASTATIN 1 MG TABLET?

Since May 7, 2025, the NADAC for PITAVASTATIN 1 MG TABLET has ranged from a low of $0.7973 (Nov 18, 2026) to a high of $1.6402 (May 14, 2025), with a median of $1.3410 per EA.

Are there cheaper alternatives to PITAVASTATIN 1 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 1 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PITAVASTATIN 1 MG TABLET?

PITAVASTATIN 1 MG TABLET (NDC 65162002909) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.